Certain Blood Flow Restriction Devices With Rotatable Windlasses and Components Thereof; Notice of Request for Submissions on the Public Interest, 22741-22742 [2024-06897]

Download as PDF Federal Register / Vol. 89, No. 64 / Tuesday, April 2, 2024 / Notices DEPARTMENT OF THE INTERIOR National Park Service [NPS–NCR–CHOH–37545; PPNCCHOHS0– PPMPSPD1Z.YM0000] Chesapeake and Ohio Canal National Historical Park Commission Notice of Public Meeting National Park Service, Interior. Meeting notice. AGENCY: ACTION: In accordance with the Federal Advisory Committee Act of 1972, as amended, the National Park Service (NPS) is hereby giving notice that the Chesapeake and Ohio Canal National Historical Park Commission (Commission) will meet as indicated below. SUMMARY: The in-person meeting will take place on Monday, May 6, 2024. The meeting will begin at 10 a.m. until 2 p.m. (EASTERN), with an hour-long lunch break. ADDRESSES: The meeting will be held in the public conference room at park headquarters, Chesapeake and Ohio Canal National Historical Park, 142 W Potomac Street, Williamsport, MD 21795. Individuals that prefer to participate virtually must contact the person listed in the (see FOR FURTHER INFORMATION CONTACT) section at least five (5) business days prior to the meeting. For updated information please see https://www.nps.gov/choh/ learn/news/federal-advisorycommission.htm or email choh_ information@nps.gov. FOR FURTHER INFORMATION CONTACT: Tina Cappetta, Superintendent, Chesapeake and Ohio Canal National Historical Park, 142 W Potomac Street, Williamsport, MD 21795, or via telephone at (301) 491–3374, or by email tina_cappetta@nps.gov. SUPPLEMENTARY INFORMATION: The Commission was established on January 8, 1971, under 16 U.S.C. 410y–4, as amended, and is regulated by the Federal Advisory Committee Act. Appendix D, Division B, Title I, section 134 of Public Law 106–554, December 21, 2000, and section 1 of Public Law 113–178, September 26, 2014, respectively. The Commission will terminate on September 26, 2024, unless reauthorized by Congress. Purpose of the Meeting: The agenda will include discussion of park updates and outline goals for Fiscal Year 2024 and beyond. The final agenda will be posted on the park’s website at https:// www.nps.gov/choh/learn/news/federaladvisory-commission.htm. The website includes meeting minutes from all prior khammond on DSKJM1Z7X2PROD with NOTICES DATES: VerDate Sep<11>2014 17:06 Apr 01, 2024 Jkt 262001 meetings. The meeting is open to the public. Interested persons may present, either orally or through written comments, information for the Commission to consider during the public meeting. Written comments will also be accepted prior to, during, or after the meeting. Members of the public may submit written comments by mailing them to Erin Cowan, Assistant to the Superintendent, Chesapeake and Ohio Canal National Historical Park, 142 W Potomac Street, Williamsport, MD 21795, (301) 491–3374, or by email choh_information@nps.gov. Comments sent via email should include Comments for May 2024 Advisory Commission Meeting in the subject line. All written comments will be provided to members of the Commission. Depending on the number of people wishing to comment and the time available, the amount of time for oral comments may be limited. All comments will be made part of the public record and will be electronically distributed to all Commission members. Detailed minutes of the meeting will be available for public inspection within 90 days of the meeting. Meeting Accessibility/Special Accommodations: The meeting is open to the public. Please make requests in advance for sign language interpreter services, assistive listening devices, or other reasonable accommodations. We ask that you contact the person listed in the (see FURTHER INFORMATION CONTACT) section of this notice at least seven (7) business days prior to the meeting to give the Department of the Interior sufficient time to process your request. All reasonable accommodation requests are managed on a case-by-case basis. Individuals in the United States who are deaf, deafblind, hard of hearing, or have a speech disability may dial 711 (TTY, TDD, or TeleBraille) to access telecommunications relay services. Individuals outside the United States should use the relay services offered within their country to make international calls to the point-ofcontact in the United States. Public Disclosure of Comments: Before including your address, phone number, email address, or other personal identifying information in your written comments, you should be aware that your entire comment including your personal identifying information will be made publicly available. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 22741 (Authority: 5 U.S.C. Ch. 10) Alma Ripps, Chief, Office of Policy. [FR Doc. 2024–06964 Filed 4–1–24; 8:45 am] BILLING CODE 4312–52–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1364] Certain Blood Flow Restriction Devices With Rotatable Windlasses and Components Thereof; Notice of Request for Submissions on the Public Interest International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that on March 19, 2024, the presiding administrative law judge (‘‘ALJ’’) issued a Recommended Determination on Remedy and Bond in the abovecaptioned investigation. The Commission is soliciting submissions on public interest issues raised by the recommended relief. This notice is soliciting comments from the public and interested government agencies only. FOR FURTHER INFORMATION CONTACT: Joelle P. Justus, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 617–1998. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: Section 337 of the Tariff Act of 1930 provides that, if the Commission finds a violation, it shall exclude the articles concerned from the United States unless, after considering the effect of such exclusion upon the public health and welfare, competitive conditions in the United States economy, the production of like or directly competitive articles in the United States, and United States consumers, it finds that such articles should not be excluded from entry. (19 U.S.C. 1337(d)(1)). A similar provision applies SUMMARY: E:\FR\FM\02APN1.SGM 02APN1 khammond on DSKJM1Z7X2PROD with NOTICES 22742 Federal Register / Vol. 89, No. 64 / Tuesday, April 2, 2024 / Notices to cease and desist orders. (19 U.S.C. 1337(f)(1)). The Commission is soliciting submissions on public interest issues raised by the recommended relief should the Commission find a violation, specifically: a general exclusion order directed to certain blood flow restriction devices with rotatable windlasses and components thereof that infringe claims 1, 4, 15, and 16 of U.S. Patent No. 7,842,067 (‘‘the ’067 patent’’) that are imported, sold for importation, and/or sold after importation; a limited exclusion order directed to certain blood flow restriction devices with rotatable windlasses and components thereof that infringe claims 1, 4, 15, and 16 of the ’067 patent, infringe U.S. Trademark Registration Nos. 3,863,064 and 5,046,378, and/or infringe the asserted Trade Dress and that are imported, sold for importation, and/or sold after importation by Respondents Anping Longji Medical Equipment Factory; Dongguanwin Si Hai Precision Mold Co., Ltd.; Eiffel Medical Supplies Co., Ltd.; Empire State Distributors Inc.; EMRN Medical Equipment; GD Tianwu New Material Tech Co., Ltd.; Hengshui Runde Medical Instruments Co., Ltd.; Putian Dima Trading Co., Ltd.; Rhino Inc.; Shanghai Sixu International Freight Agent Co., Ltd.; Shenzhen Anben E-Commerce Co., Ltd.; Shenzhen TMI Medical Supplies Co., Ltd.; Shenzhen Yujie Commercial and Trading Co., Ltd.; Wuxi Emsrun Technology Co., Ltd.; Wuxi Golden Hour Medical Technology Co., Ltd.; and Wuxi Puneda Technology Co., Ltd. (collectively, ‘‘Defaulting Respondents’’); and cease and desist orders directed to each Defaulting Respondent. Parties are to file public interest submissions pursuant to 19 CFR 210.50(a)(4). The Commission is interested in further development of the record on the public interest in this investigation. Accordingly, members of the public and interested government agencies are invited to file submissions of no more than five (5) pages, inclusive of attachments, concerning the public interest in light of the ALJ’s Recommended Determination on Remedy and Bond issued in this investigation on March 19, 2024. Comments should address whether issuance of the recommended remedial orders in this investigation would affect the public health and welfare in the United States, competitive conditions in the United States economy, the production of like or directly competitive articles in the United States, or United States consumers. VerDate Sep<11>2014 17:06 Apr 01, 2024 Jkt 262001 In particular, the Commission is interested in comments that: (i) explain how the articles potentially subject to the recommended remedial orders are used in the United States; (ii) identify any public health, safety, or welfare concerns in the United States relating to the recommended orders; (iii) identify like or directly competitive articles that complainant, its licensees, or third parties make in the United States which could replace the subject articles if they were to be excluded; (iv) indicate whether complainant, complainant’s licensees, and/or thirdparty suppliers have the capacity to replace the volume of articles potentially subject to the recommended orders within a commercially reasonable time; and (v) explain how the recommended orders would impact consumers in the United States. Written submissions must be filed no later than by close of business on April 26, 2024. Persons filing written submissions must file the original document electronically on or before the deadlines stated above. The Commission’s paper filing requirements in 19 CFR 210.4(f) are currently waived. 85 FR 15798 (Mar. 19, 2020). Submissions should refer to the investigation number (‘‘Inv. No. 337–TA–1364’’) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, https://www.usitc.gov/ secretary/fed_reg_notices/rules/ handbook_on_electronic_filing.pdf). Persons with questions regarding filing should contact the Secretary (202–205– 2000). Any person desiring to submit a document to the Commission in confidence must request confidential treatment by marking each document with a header indicating that the document contains confidential information. This marking will be deemed to satisfy the request procedure set forth in Rules 201.6(b) and 210.5(e)(2) (19 CFR 201.6(b) & 210.5(e)(2)). Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. Any non-party wishing to submit comments containing confidential information must serve those comments on the parties to the investigation pursuant to the applicable Administrative Protective Order. A redacted non-confidential version of the document must also be filed simultaneously with any confidential filing and must be served in accordance with Commission Rule 210.4(f)(7)(ii)(A) (19 CFR 210.4(f)(7)(ii)(A)). All PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this investigation may be disclosed to and used: (i) by the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel, solely for cybersecurity purposes. All contract personnel will sign appropriate nondisclosure agreements. All nonconfidential written submissions will be available for public inspection on EDIS. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: March 25, 2024. Katherine Hiner, Supervisory Attorney. [FR Doc. 2024–06897 Filed 4–1–24; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE [OMB Number 1117–0043] Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Drug Use Statement Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Drug Enforcement Administration, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register on December 24, 2024 allowing a 60-day comment period. DATES: Comments are encouraged and will be accepted for 30 days until June 3, 2024. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public SUMMARY: E:\FR\FM\02APN1.SGM 02APN1

Agencies

INTERNATIONAL TRADE COMMISSION

[Federal Register Volume 89, Number 64 (Tuesday, April 2, 2024)]
[Notices]
[Pages 22741-22742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06897]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1364]


Certain Blood Flow Restriction Devices With Rotatable Windlasses 
and Components Thereof; Notice of Request for Submissions on the Public 
Interest

AGENCY: International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that on March 19, 2024, the presiding 
administrative law judge (``ALJ'') issued a Recommended Determination 
on Remedy and Bond in the above-captioned investigation. The Commission 
is soliciting submissions on public interest issues raised by the 
recommended relief. This notice is soliciting comments from the public 
and interested government agencies only.

FOR FURTHER INFORMATION CONTACT: Joelle P. Justus, Esq., Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 617-1998. Copies of non-
confidential documents filed in connection with this investigation may 
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email 
[email protected]. General information concerning the Commission may 
also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on 
this matter can be obtained by contacting the Commission's TDD terminal 
on (202) 205-1810.

SUPPLEMENTARY INFORMATION: Section 337 of the Tariff Act of 1930 
provides that, if the Commission finds a violation, it shall exclude 
the articles concerned from the United States unless, after considering 
the effect of such exclusion upon the public health and welfare, 
competitive conditions in the United States economy, the production of 
like or directly competitive articles in the United States, and United 
States consumers, it finds that such articles should not be excluded 
from entry. (19 U.S.C. 1337(d)(1)). A similar provision applies

[[Page 22742]]

to cease and desist orders. (19 U.S.C. 1337(f)(1)).
    The Commission is soliciting submissions on public interest issues 
raised by the recommended relief should the Commission find a 
violation, specifically: a general exclusion order directed to certain 
blood flow restriction devices with rotatable windlasses and components 
thereof that infringe claims 1, 4, 15, and 16 of U.S. Patent No. 
7,842,067 (``the '067 patent'') that are imported, sold for 
importation, and/or sold after importation; a limited exclusion order 
directed to certain blood flow restriction devices with rotatable 
windlasses and components thereof that infringe claims 1, 4, 15, and 16 
of the '067 patent, infringe U.S. Trademark Registration Nos. 3,863,064 
and 5,046,378, and/or infringe the asserted Trade Dress and that are 
imported, sold for importation, and/or sold after importation by 
Respondents Anping Longji Medical Equipment Factory; Dongguanwin Si Hai 
Precision Mold Co., Ltd.; Eiffel Medical Supplies Co., Ltd.; Empire 
State Distributors Inc.; EMRN Medical Equipment; GD Tianwu New Material 
Tech Co., Ltd.; Hengshui Runde Medical Instruments Co., Ltd.; Putian 
Dima Trading Co., Ltd.; Rhino Inc.; Shanghai Sixu International Freight 
Agent Co., Ltd.; Shenzhen Anben E-Commerce Co., Ltd.; Shenzhen TMI 
Medical Supplies Co., Ltd.; Shenzhen Yujie Commercial and Trading Co., 
Ltd.; Wuxi Emsrun Technology Co., Ltd.; Wuxi Golden Hour Medical 
Technology Co., Ltd.; and Wuxi Puneda Technology Co., Ltd. 
(collectively, ``Defaulting Respondents''); and cease and desist orders 
directed to each Defaulting Respondent. Parties are to file public 
interest submissions pursuant to 19 CFR 210.50(a)(4).
    The Commission is interested in further development of the record 
on the public interest in this investigation. Accordingly, members of 
the public and interested government agencies are invited to file 
submissions of no more than five (5) pages, inclusive of attachments, 
concerning the public interest in light of the ALJ's Recommended 
Determination on Remedy and Bond issued in this investigation on March 
19, 2024. Comments should address whether issuance of the recommended 
remedial orders in this investigation would affect the public health 
and welfare in the United States, competitive conditions in the United 
States economy, the production of like or directly competitive articles 
in the United States, or United States consumers.
    In particular, the Commission is interested in comments that:
    (i) explain how the articles potentially subject to the recommended 
remedial orders are used in the United States;
    (ii) identify any public health, safety, or welfare concerns in the 
United States relating to the recommended orders;
    (iii) identify like or directly competitive articles that 
complainant, its licensees, or third parties make in the United States 
which could replace the subject articles if they were to be excluded;
    (iv) indicate whether complainant, complainant's licensees, and/or 
third-party suppliers have the capacity to replace the volume of 
articles potentially subject to the recommended orders within a 
commercially reasonable time; and
    (v) explain how the recommended orders would impact consumers in 
the United States.
    Written submissions must be filed no later than by close of 
business on April 26, 2024.
    Persons filing written submissions must file the original document 
electronically on or before the deadlines stated above. The 
Commission's paper filing requirements in 19 CFR 210.4(f) are currently 
waived. 85 FR 15798 (Mar. 19, 2020). Submissions should refer to the 
investigation number (``Inv. No. 337-TA-1364'') in a prominent place on 
the cover page and/or the first page. (See Handbook for Electronic 
Filing Procedures, https://www.usitc.gov/secretary/fed_reg_notices/rules/handbook_on_electronic_filing.pdf). Persons with questions 
regarding filing should contact the Secretary (202-205-2000).
    Any person desiring to submit a document to the Commission in 
confidence must request confidential treatment by marking each document 
with a header indicating that the document contains confidential 
information. This marking will be deemed to satisfy the request 
procedure set forth in Rules 201.6(b) and 210.5(e)(2) (19 CFR 201.6(b) 
& 210.5(e)(2)). Documents for which confidential treatment by the 
Commission is properly sought will be treated accordingly. Any non-
party wishing to submit comments containing confidential information 
must serve those comments on the parties to the investigation pursuant 
to the applicable Administrative Protective Order. A redacted non-
confidential version of the document must also be filed simultaneously 
with any confidential filing and must be served in accordance with 
Commission Rule 210.4(f)(7)(ii)(A) (19 CFR 210.4(f)(7)(ii)(A)). All 
information, including confidential business information and documents 
for which confidential treatment is properly sought, submitted to the 
Commission for purposes of this investigation may be disclosed to and 
used: (i) by the Commission, its employees and Offices, and contract 
personnel (a) for developing or maintaining the records of this or a 
related proceeding, or (b) in internal investigations, audits, reviews, 
and evaluations relating to the programs, personnel, and operations of 
the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. 
government employees and contract personnel, solely for cybersecurity 
purposes. All contract personnel will sign appropriate nondisclosure 
agreements. All nonconfidential written submissions will be available 
for public inspection on EDIS.
    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the 
Commission's Rules of Practice and Procedure (19 CFR part 210).

    By order of the Commission.

    Issued: March 25, 2024.
Katherine Hiner,
Supervisory Attorney.
[FR Doc. 2024-06897 Filed 4-1-24; 8:45 am]
BILLING CODE 7020-02-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.